A recent General Surgery digest,
as sent to subscribers

Study Type: Retrospective cohort study

Key Question: What are the pathological outcomes in esophageal cancer patients with uncertain clinical response to neoadjuvant chemoradiotherapy?

Key Findings:

• Only 15% (95% CI 10-20%) of patients with uncertain response had complete pathological response at resection
• Highest complete pathological response rates were in non-traversable lesions (26%) versus high-grade dysplasia (10%) or clinical suspicion groups (8%)
• Squamous cell carcinoma patients with non-traversable lesions had the best outcomes (33% complete pathological response, 95% CI 21-48%)

Clinical Relevance: Helps UK oesophageal surgeons counsel patients with equivocal post-neoadjuvant imaging, as 85% will have residual disease requiring resection rather than active surveillance.

Limitations: Retrospective analysis from a single trial cohort may limit generalisability to broader UK practice.

Study Type: Retrospective cohort study

Key Question: How does pancreatic cancer risk during IPMN surveillance compare to the general population, and which factors influence this risk?

Key Findings:

• IPMN patients had 10-fold higher pancreatic cancer risk versus age-matched SEER controls (SIR 10.0, CI: 7.2-15.6) with cumulative malignancy incidence of 0.97% at 60 months
• Highest risk subgroups included main pancreatic duct dilatation ≥5mm (SIR 26.5) and BMI ≥30 (SIR 20.6)
• Even "guideline-negative" cysts (<3cm, no duct dilatation/solid component) showed 8.4-fold increased cancer risk versus general population

Clinical Relevance: This challenges current "watch and wait" approaches for small IPMNs, suggesting that even low-risk lesions may warrant closer surveillance than population screening in UK practice.

Limitations: Single-centre retrospective study may not reflect broader UK population demographics and healthcare delivery patterns.

Study Type: Retrospective cohort study using difference-in-differences analysis

Key Question: Does private equity acquisition of rural hospitals affect surgical quality outcomes for common general surgery procedures?

Key Findings:

• Private equity acquisition was associated with increased 30-day mortality (1.1 percentage point increase, P=0.04) among 96,048 Medicare patients across 390 rural hospitals
• Complications increased by 2.5 percentage points (P=0.03) and serious complications by 1.5 percentage points (P=0.02) following acquisition
• Effects persisted despite controlling for hospital characteristics and patient demographics

Clinical Relevance: Though US-focused, this raises important questions about healthcare ownership models that may be relevant as private equity involvement in UK healthcare increases, particularly affecting rural service provision.

Limitations: Limited to Medicare beneficiaries and US rural hospitals, which may not generalise to UK NHS settings or younger patient populations.

Study Type: Retrospective cohort study with algorithm development and external validation

Key Question: Can administrative data and procedure codes accurately classify 30-day postoperative complications using Clavien-Dindo grading in hepatobiliary surgery?

Key Findings:

• Expert-derived algorithm achieved excellent performance: macro-F1 score 0.962 (95% CI: 0.946-0.977), sensitivity 0.950, specificity 0.971, and weighted-kappa 0.928
• Algorithm outperformed machine learning approaches (RandomForest, ElasticNet, XGBoost) across all metrics
• Misclassification rate was only 3.2%, mainly due to ICU timing issues or incomplete coding

Clinical Relevance: This validated algorithm could enable NHS trusts to automatically monitor hepatobiliary surgical outcomes and benchmark performance using existing administrative data, potentially reducing manual audit burden and enabling real-time quality surveillance.

Limitations: Development and validation limited to French centres with specific coding practices, requiring validation in NHS administrative datasets before implementation.

Study Type: Retrospective multicenter cohort study

Key Question: Does surgical therapy for gastroparesis improve glycemic control and reduce diabetes-related complications in patients with diabetic gastroparesis?

Key Findings:

• Mean HbA1c at 5 years was significantly lower in surgical vs non-operative patients (6.29% vs 7.21%, difference 0.92 percentage points, P<0.001)
• Surgical patients had reduced diabetes-related complications (53.2% vs 63.3%, OR 1.52, 95% CI 1.34-1.71)
• Emergency visits and hospitalizations were less frequent in surgical patients (41.7% vs 54.7% and 45.5% vs 59.0% respectively)

Clinical Relevance: This suggests gastroparesis surgery may offer metabolic benefits beyond symptom relief, potentially influencing surgical decision-making in diabetic patients with refractory gastroparesis within NHS diabetes and surgical services.

Limitations: Retrospective design with potential unmeasured confounders despite propensity matching may limit causal inference.

Study Type: Retrospective cohort study

Key Question: What is the optimal anatomical mesh placement technique for primary ventral hernia repair in terms of recurrence and bowel obstruction risk?

Key Findings:

• Retromuscular mesh placement increased recurrence risk by 63% (HR 1.63, 95% CI 1.12-2.38) and bowel obstruction risk by 101% (HR 2.01, 95% CI 1.05-3.82) compared to onlay placement
• IPOM increased recurrence risk by 38% (HR 1.38, 95% CI 1.02-1.86) and bowel obstruction risk by 247% (HR 3.47, 95% CI 2.27-5.28) compared to onlay placement
• Preperitoneal mesh placement showed no significant difference in outcomes compared to onlay placement

Clinical Relevance: This large-scale study challenges current practices favouring posterior mesh placement techniques and suggests onlay or preperitoneal approaches may be safer for primary ventral hernias, informing NHS surgical decision-making.

Limitations: Register-based study design may have incomplete data on surgical technique details and patient-specific factors influencing mesh placement choice.

Study Type: Randomized controlled trial

Key Question: Does portal-venous hypothermic oxygenated perfusion (HOPE) improve outcomes compared to static cold storage alone in extended criteria donor liver transplants?

Key Findings:

• Early allograft dysfunction reduced from 37.3% with cold storage to 20.2% with HOPE (absolute reduction 17.1%, 95% CI -27.2 to -7.0, P=0.005)
• HOPE group had significantly lower MEAF scores (4.28 vs 4.82, P=0.03) and shorter hospital stay (HR 1.32, P=0.04)
• One-year patient and graft survival were comparable between groups (>95% in both)

Clinical Relevance: This provides strong evidence for adopting HOPE technology in UK liver transplant centres, particularly relevant given increasing use of extended criteria donors to address organ shortage.

Limitations: Open-label design with potential for bias, though primary outcomes were objectively defined and imaging assessment was blinded.